marijuana stocks

Form 8-K for LEXARIA CORP.


24-Aug-2015

Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure.A copy of the news release announcing the Company’s technology achieves Cannabidiol absorption rate 499% greater than baseline in laboratory testing filed as exhibit 99.1 to this current report and is hereby incorporated by reference.

 


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Cara Therapeutics, Inc. (CARA) Appoints Helen M. Boudreau to Board of Directors

Cara Therapeutics Appoints Helen M. Boudreau to Board of Directors Cara Therapeutics,…

$CTCO Creates Market Entry Strategy With Plans Aided by Impressive Executive MBA Teams

Peak Pharmaceuticals Develops Market Entry Strategy and Plan Aided by Outstanding Executive…

GrowGeneration Corp. (GRWG) Acquires Mendocino Greenhouse and Garden Supply

GrowGeneration Acquires Mendocino Greenhouse and Garden Supply, Expands Footprint in California’s Emerald…

$MDBX Appoints new Director & VP

Medbox Appoints Tim Morrissey as V.P. and Director of Vaporfection Morrissey Built…